[landscape-gap] GWAS & Genetic Cell Type Enrichment: Cell-type enrichment results vary across methods; fine-mapping to causal cell types is inconclusive; rare variant cell-type effects are largely unexplored.

OPEN

Mapping genetic disease risk (GWAS loci) to specific brain cell types using single-cell expression data. Includes MAGMA-cell, LDSC-SEG, and single-cell Mendelian randomization approaches for neuropsychiatric and neurodegenerative diseases. | Gap: Cell-type enrichment results vary across methods; fine-mapping to causal cell types is inconclusive; rare variant cell-type effects are largely unexplored.

Priority: 0.80 Domain: human-brain-cell-types Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: [landscape-gap] GWAS & Genetic Cell Type Enrichment: Cell-type enrichment results vary across methods; fine-mapping to causal cell types is inconclusive; rare variant cell-type effects are largely unexplored. is a 0.8 priority gap in human-brain-cell-types. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

[landscape-gap] GWAS & Genetic Cell Type Enrichment: Cell-type enrichment results vary across methods; fine-mapping to causal cell types is inconclusive; rare variant cell-type effects are largely unexplored. — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

associated with (1)

GWASAlzheimer's disease
🕑 Activity Feed
update on knowledge_gap by None 2026-04-28T08:22
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps